Guest: Pamela L. Kunz, MD
In 2015, there were an estimated 291,150 new cases of digestive system cancers in the United States, with an estimated 149,300 deaths (American Cancer Society, 2015). Having access to the most recent clinical advances in GI malignancies is crucial to making informed and timely treatment decisions. In this activity, an expert faculty member will highlight the most exciting and compelling data in pancreatic cancer, pancreatic neuroendocrine tumors (pNET), and GI neuroendocrine tumors (GI-NET), and provide insights on how these clinical advances may be practice changing.
View all episodes
